Insulinoma Companies

ID: MRFR/HC/3026-HCR

200 Pages

Vikita Thakur

Last Updated: February 16, 2025

Insulinoma is a rare type of tumor that forms in the pancreas and is typically associated with an overproduction of insulin, leading to hypoglycemia (low blood sugar). Companies addressing insulinoma may be involved in the development of diagnostic tools, treatment options, and research related to this condition.

Insulinoma Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.3%

2024 Market Size$ 450 Million

2025 Market Size$ 473.85 Million

2035 Market Size$ 794.19 Million

Key Players

Bristol-Myers Squibb

Eli Lilly and Company

Sanofi

Novo Nordisk

AstraZeneca

Pfizer

Trends

Advancements in Diagnostic Techniques
Personalized Treatment Approaches
Increased Research and Collaboration

Opportunities

Rising Incidence of Insulinoma
Increased Awareness and Education
Advancements in Treatment Modalities

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Insulinoma Market

Latest Insulinoma Treatment Companies Update:

Ipsen Pharma acquired Synta Pharmaceuticals, gaining access to their lead investigational drug for insulinoma, SOM230. This signifies Ipsen's commitment to expanding their presence in the insulinoma treatment market.

Johnson & Johnson partnered with University of California, San Diego, to develop novel therapies for pancreatic neuroendocrine tumors (NETs), which include insulinomas. This collaboration leverages J&J's expertise in drug development with UCSD's research strengths in NETs.

Teva Pharmaceuticals received FDA approval for lanreotide acetate injection (Somatuline Depot), a long-acting somatostatin analog, for the treatment of acromegaly and insulinoma. This expands Teva's portfolio of NET treatment options.

Novartis launched Lutathera® (lutetium Lu 177 dotatate) in the US, a radiopharmaceutical therapy for patients with inoperable gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including insulinomas. This offers a new treatment option for advanced cases.

List of Insulinoma Treatment companies in the market

Abcam plc
cironpharma
Pfizer Plc.
Entax Medical
Olympus
Boston Scientific Corporation
Medtronic
Cook Medical
Cook Medical, Inc

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”